- Home
- AMPG vs BCDA Comparison
AMPG vs BCDA Comparison
Compare AMPG & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPG
- BCDA
- Stock Information
- Founded
- AMPG 2002
- BCDA N/A
- Country
- AMPG United States
- BCDA United States
- Employees
- AMPG N/A
- BCDA N/A
- Industry
- AMPG Telecommunications Equipment
- BCDA Biotechnology: Pharmaceutical Preparations
- Sector
- AMPG Telecommunications
- BCDA Health Care
- Exchange
- AMPG Nasdaq
- BCDA Nasdaq
- Market Cap
- AMPG 9.8M
- BCDA 7.9M
- IPO Year
- AMPG N/A
- BCDA N/A
- Fundamental
- Price
- AMPG $0.86
- BCDA $2.68
- Analyst Decision
- AMPG Strong Buy
- BCDA Strong Buy
- Analyst Count
- AMPG 1
- BCDA 1
- Target Price
- AMPG $5.00
- BCDA $25.00
- AVG Volume (30 Days)
- AMPG 26.2K
- BCDA 73.1K
- Earning Date
- AMPG 11-12-2024
- BCDA 11-06-2024
- Dividend Yield
- AMPG N/A
- BCDA N/A
- EPS Growth
- AMPG N/A
- BCDA N/A
- EPS
- AMPG N/A
- BCDA N/A
- Revenue
- AMPG $12,219,820.00
- BCDA $428,000.00
- Revenue This Year
- AMPG N/A
- BCDA $6.92
- Revenue Next Year
- AMPG $218.18
- BCDA N/A
- P/E Ratio
- AMPG N/A
- BCDA N/A
- Revenue Growth
- AMPG N/A
- BCDA 0.71
- 52 Week Low
- AMPG $0.64
- BCDA $1.96
- 52 Week High
- AMPG $2.55
- BCDA $23.25
- Technical
- Relative Strength Index (RSI)
- AMPG 54.50
- BCDA 49.01
- Support Level
- AMPG $0.70
- BCDA $2.39
- Resistance Level
- AMPG $0.89
- BCDA $2.90
- Average True Range (ATR)
- AMPG 0.04
- BCDA 0.18
- MACD
- AMPG 0.01
- BCDA -0.00
- Stochastic Oscillator
- AMPG 85.03
- BCDA 53.70
About AMPG Amplitech Group Inc.
AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.
About BCDA BioCardia Inc.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).